Agilent Launches S540MD Slide Scanner in the U.S. Following FDA Clearance
Agilent Technologies Inc. has announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner designed to support high-throughput digital pathology workflows. The commercial introduction follows U.S. Food and Drug Administration (FDA) clearance and represents another step in Agilent’s efforts to expand its presence in digital pathology and provide clinical laboratories with technologies capable of supporting increasingly digital diagnostic environments.
The launch comes as pathology laboratories face growing demands to process higher numbers of patient samples while maintaining diagnostic quality, operational efficiency, and turnaround times. At the same time, laboratories are increasingly evaluating digital pathology and artificial intelligence (AI)-enabled technologies as part of their long-term modernization strategies.
With its high slide capacity, continuous loading capabilities, automated scanning functions, and advanced tissue detection, the Agilent S540MD has been developed to help laboratories digitize large volumes of glass slides and incorporate whole slide imaging into routine pathology operations.
Supporting the Shift Toward Digital Pathology
Pathology remains a critical component of healthcare, providing diagnostic information that helps physicians identify diseases, determine their severity, and guide treatment decisions. Traditionally, pathologists have relied on glass slides viewed through conventional microscopes. However, advances in digital pathology have created opportunities to convert these physical slides into high-resolution digital images that can be viewed, managed, shared, and analyzed electronically.
The transition to digital workflows can offer laboratories several potential advantages. Digital slides can facilitate remote access, collaboration among pathologists, electronic case management, and integration with advanced analytical tools. Digital images can also serve as an important foundation for the development and implementation of AI-based pathology applications.
As more laboratories explore these capabilities, the need for reliable scanning infrastructure has increased. High-throughput laboratories, in particular, require scanners that can process substantial numbers of slides without creating additional operational bottlenecks.
The Agilent S540MD is designed with this environment in mind. Its capacity for up to 540 slides allows laboratories to digitize large batches of specimens, while continuous loading is intended to support more efficient laboratory operations.
Designed for High-Volume Scanning
A central feature of the Agilent S540MD is its emphasis on speed and scalability. The system can accommodate up to 540 slides and supports continuous loading, allowing laboratory personnel to load slides without relying solely on small batches.
This capability can be particularly important in laboratories handling significant daily sample volumes. Instead of requiring frequent manual intervention, a high-capacity scanning system can help laboratories maintain a more consistent digitization workflow.
The scanner also supports standard rack compatibility, which is designed to facilitate integration into laboratory environments and existing slide-handling processes. By aligning with familiar laboratory practices, the system aims to help organizations incorporate digital scanning without unnecessarily disrupting established workflows.
Automated scanning modes further contribute to the system’s high-throughput design. Automation can reduce repetitive manual tasks and help laboratories manage large numbers of slides more efficiently.
Another important capability is advanced tissue detection, which helps the scanner identify tissue areas on slides during the digitization process. Such features are intended to support efficient image acquisition and reduce unnecessary scanning of areas that do not contain relevant tissue.
Together, these capabilities position the Agilent S540MD as a solution aimed at laboratories looking to expand digital pathology operations while managing increasing workloads.
Preparing Laboratories for AI-Enabled Workflows
The development of digital pathology is closely connected to the growing interest in artificial intelligence. AI technologies are increasingly being explored for applications such as image analysis, pattern recognition, decision support, and workflow optimization.
High-quality whole slide images are a fundamental requirement for many digital pathology and AI applications. Before digital images can be analyzed by pathologists or computational tools, physical glass slides must first be converted into usable digital data.
Consequently, scanners represent an important component of the digital pathology infrastructure. The ability to efficiently digitize large numbers of slides can help laboratories establish the image libraries and digital workflows required for future applications.
Agilent’s launch of the S540MD reflects this broader shift. Rather than focusing only on the immediate need to scan slides, the company is positioning the system as part of a digital transformation strategy that can support laboratories as they increasingly adopt digital and AI-enabled processes.
For pathology organizations considering AI integration, scalable scanning capacity can be particularly important. As the number of digitally processed cases grows, laboratories need infrastructure capable of keeping pace with expanding image volumes.
Agilent Expands Its Digital Pathology Portfolio
The introduction of the S540MD adds another high-throughput scanning option to Agilent’s broader clinical diagnostics and pathology portfolio. The company has been investing in digital pathology technologies as laboratories increasingly seek integrated solutions covering different stages of the pathology workflow.
Majken Nielsen, vice president and general manager of Agilent’s Clinical Diagnostics Division, described the U.S. launch as an important milestone in the company’s efforts to help customers advance their digital pathology capabilities.
According to Nielsen, the combination of advanced scanning technology and Agilent’s pathology expertise is intended to provide laboratories with an integrated experience that supports evolving diagnostic and workflow requirements.
The company’s approach reflects a broader trend in laboratory diagnostics, where customers increasingly look for technologies that can work within existing operations while providing a pathway toward future capabilities.
Building on European Market Introduction
The U.S. launch follows Agilent’s introduction of the S540MD in selected European markets in January 2026. The subsequent FDA clearance and U.S. commercial launch expand the system’s availability and represent an additional milestone in the company’s digital pathology strategy.
The scanner is now available in the United States as well as a broad group of European markets. These include Germany, the United Kingdom, France, Italy, Spain, Switzerland, Austria, Belgium, the Netherlands, Luxembourg, Denmark, Sweden, Norway, and Finland.
The geographic expansion demonstrates Agilent’s intention to make high-throughput digital pathology technology available to laboratories across multiple healthcare markets.
The company’s continued rollout also comes at a time when healthcare organizations worldwide are evaluating how digital technologies can help improve laboratory productivity and support changing diagnostic requirements.
Agilent-Branded Version of Established Scanning Technology
The Agilent S540MD Slide Scanner System is the Agilent-branded version of the Hamamatsu NanoZoomer S540MD Slide Scanner System. By bringing the scanner into its own portfolio, Agilent is incorporating the technology into its broader offering for pathology and clinical diagnostics customers.
For laboratories, access to scanning technology through an established diagnostics provider can potentially simplify technology selection and support broader integration with other pathology-related products and services.
The scanner’s design focuses on the practical needs of high-volume pathology environments, where large numbers of slides must be digitized accurately and efficiently.
Features such as continuous loading and automated scanning are particularly relevant for laboratories seeking to reduce manual intervention. Meanwhile, the system’s high capacity provides an opportunity to scale digital slide production as laboratory demand increases.
Addressing Operational Challenges in Modern Laboratories
Pathology laboratories operate under continuing pressure to improve efficiency while maintaining diagnostic standards. Increasing sample volumes, workforce considerations, turnaround-time expectations, and the growing complexity of diagnostic testing all contribute to the need for more streamlined workflows.
Digital pathology can help laboratories rethink how slides are reviewed and managed. Instead of physically transporting glass slides between locations, digital images can be accessed electronically, depending on the laboratory’s infrastructure and applicable regulatory requirements.
Digitization can also support collaboration, education, consultation, and archiving. In addition, digital images can provide a foundation for computational analysis and AI-based applications.
However, these benefits depend on laboratories having reliable scanning systems capable of producing digital images at the scale required for routine operations. High-throughput scanners such as the S540MD are therefore becoming increasingly relevant as organizations move beyond pilot projects and begin implementing digital pathology across larger portions of their workflows.
Supporting the Future of Diagnostic Workflows
The launch of the Agilent S540MD reflects the continued transformation of pathology from predominantly microscope-based processes toward increasingly connected digital workflows.
For laboratories beginning or expanding their digital pathology programs, scalability is likely to remain a major consideration. A system capable of processing hundreds of slides can provide greater flexibility as digital case volumes increase.
The scanner’s automated capabilities may also help laboratory teams focus their time on higher-value activities rather than repetitive slide-loading and scanning tasks. Advanced tissue detection adds another layer of automation by supporting the identification of relevant tissue areas during image acquisition.
As AI adoption in pathology continues to develop, the importance of robust digital infrastructure is expected to grow. High-quality whole slide imaging can provide the underlying data needed for many emerging computational pathology applications.
Agilent’s investment in this area therefore extends beyond the introduction of a single scanner. The company is responding to a broader movement toward digitally enabled diagnostic laboratories and the increasing convergence of pathology, automation, imaging, and AI.
A Milestone in Agilent’s Digital Pathology Strategy
With FDA clearance now supporting U.S. commercialization, the Agilent S540MD Slide Scanner System represents a significant addition to Agilent’s digital pathology offering. Its combination of high slide capacity, continuous loading, automated scanning, tissue detection, standard rack compatibility, and extended market availability is designed to address the operational demands of modern pathology laboratories.
The system’s introduction also highlights the changing expectations surrounding pathology technology. Laboratories are no longer simply looking for equipment that can digitize individual slides; many are seeking scalable platforms that can support enterprise-level digital workflows and future technologies.
Agilent’s U.S. launch, following its European market introduction earlier in 2026, positions the company to support laboratories as they continue their transition toward digital pathology. By providing infrastructure capable of handling high volumes of glass slides, the S540MD is intended to help laboratories improve workflow efficiency while establishing a foundation for broader digital and AI-enabled diagnostic applications.
As healthcare organizations continue investing in laboratory modernization, technologies that combine automation, scalability, and digital connectivity are likely to play an increasingly important role. The Agilent S540MD is designed to meet that need by helping pathology laboratories move more efficiently from traditional glass-slide processes toward scalable whole slide imaging and the next generation of digitally supported diagnostics.
About Agilent Technologies
Agilent Technologies, Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers’ most challenging questions. The company generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide.